Nadine Schwarz: How Genetic Variation Shapes Protein C Pathway Function
Nadine Schwarz, Research Associate at Institute of Experimental Hematology and Transfusion Medicine in University Hospital Bonn, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
“Excited to share our latest publication in Blood Advances!
We investigated how common genetic variants in THBD and PROCR influence the anticoagulant response of the protein C pathway using both in vivo and ex vivo experimental models.
By combining controlled coagulation activation in human participants with endothelial cell-based functional assays, we were able to dissect the distinct effects of these variants on protein C pathway function.
I am grateful to all my colleagues and co-authors who contributed to this study.”
Title: In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway
Authors: Sara Reda, Nadine Schwarz, Sebastian Eckert, Jens Müller, Johannes Oldenburg, Bernd Pötzsch, Behnaz Pezeshkpoor, Heiko Rühl

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments